CClinicalTrials.gg
CompletedNCT01915095Updated Jun 11, 2021Results posted

Improving Motor Function After Spinal Cord Injury

An interventional study of rTMS and Sham rTMS in Spinal Cord Injury, sponsored by VA Office of Research and Development. Completed at 3 sites in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-11.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The goals of this study are to examine the physiology of Central Nervous System pathways contributing to the control of upper and lower extremity movements after SCI, and to promote the recovery of extremity movements by using non-invasive brain stimulation and motor training.

Read the detailed description

This study will consist of electromyography (surface and intramuscular), peripheral nerve stimulation, and transcranial magnetic stimulation, electrical stimulation, of the hand, arm, leg, and foot representation of the primary motor cortex, as well as MRI scans of the brain. The investigators will examine the physiological measurements of upper and lower extremity muscles (such as in the first dorsal interosseous (FDI), biceps brachii (BIC), anterior deltoid (AD), tibialis anterior (TA), hamstring (HAMS) and quadriceps (QUAD)). This study may occur at the Miami Project to cure Paralysis at the University of Miami. The investigators will include subjects between the ages of 18 and 85, both healthy controls and individuals with chronic spinal cord injuries that occurred at least 6 months prior to recruitment. Both healthy controls and those with spinal cord injuries will be able to perform small hand and arm movements and small leg and foot movements. The primary outcome measures of this study are muscle responses to stimulation with magnetic pulses using TMS and electrical stimulation of a peripheral nerve in the arm or leg. The investigators propose to enhance the recovery of motor function by using new protocols of high frequency non-invasive repetitive TMS (rTMS) and motor training. Repetitive TMS will be used during hand, arm, leg and foot movements in a task-dependent manner to induce cortical plasticity and enhance voluntary output of the muscles associated with those movements. Second, rTMS will be applied in a task-dependent manner during a visuo-motor training task that also involves movements of the hands, arms, legs or feet.

02

Conditions studied

  • Spinal Cord Injury

Keywords

  • spinal cord injury
  • neural control
  • motor function
  • hand movement
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 42 is above the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Male and female Veterans and non Veterans with spinal cord injury at least 6 months after injury was sustained. The investigators also plan to enroll control subjects who do not have any history of spinal cord injury.

Participants who are unimpaired healthy controls:

  • Male and females between ages 18-85 years
  • Right handed
  • Able to complete precision grips with both hands
  • Able to complete full wrist flexion-extension bilaterally
  • Able to walk unassisted
  • Able to complete full ankle flexion-extension bilaterally

Participants who have had a spinal cord injury:

  • Male and females between ages 18-85 years
  • Chronic SCI ( 6 months of injury)
  • Spinal Cord injury at or above L5
  • The ability to produce a visible precision grip force with one hand
  • Individuals who have the ability to pick up a small object (large paperclip) from a table independently
  • Able to perform some small wrist flexion and extension (measured by a goniometer)
  • The ability to perform a small visible contraction with dorsiflexor and hip flexor muscles
  • No subjects will be excluded based on their race, religion, ethnicity, gender or HIV status.

Exclusion criteria

Exclusion Criteria:

Exclusion criteria for enrollment For SCI and Healthy Control Subjects (for stimulation):

  • Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease
  • Any debilitating disease prior to the SCI that caused exercise intolerance
  • Premorbid, ongoing major depression or psychosis, altered cognitive status
  • History of head injury or stroke
  • Metal plate in skull
  • History of seizures
  • Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold (see appendix 2)
  • Pregnant females
  • Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease such as spinal stenosis, spina bifida, MS, or herniated cervical disk
  • Individuals with scalp shrapnel, cochlear implants, or aneurysm clips.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
42 participants (actual)

Study arms

  • Active comparator
    Motor task+ Magnetic stimulation

    Participants will be asked to complete a precision grip with the index and thumb finger at the same time as flexing or extending the wrist. magnetic stimulation to the brain will be administered and measurements will be taken during movement.

    Device: rTMS · Device: Sham rTMS · Other: Motor Task

  • Active comparator
    rTMS/sham rTMS

    Participant will be randomly assigned to one of 3 groups: repetitive transcranial magnetic stimulation (rTMS), sham (fake) rTMS, or sham (fake) rTMS over control brain area will be administered to the brain. the stimulation will be targeting finger and wrist muscles during movement.

    Device: rTMS · Device: Sham rTMS

  • Active comparator
    Training + rTMS/ Sham rTMS

    Participants will be asked to follow a target line on the computer as accurately as possible while performing precision grips or foot movement . Magnetic stimulation will be given during rest and movement.

    Device: rTMS · Device: Sham rTMS · Other: Training

Interventions

  • DevicerTMS

    small magnetic pulses will be given to the brain in a non invasive manner.

  • DeviceSham rTMS

    sham or fake stimulation (TMS or rTMS) will be given to the brain in a non invasive manner

  • OtherTraining

    at the direction of the researcher the participant will be instructed to do repetitive motor movements with their arm, hand or leg. this is called training

  • OtherMotor Task

    participants will be asked to perform specific motor tasks or movements with their fingers, hands, arms or legs.

06

What researchers measure

Primary outcomes

  1. Physiology Measurements Before and After rTMS/Sham rTMS Protocol- Changes in Amplitude of Motor Evoked Potential (MEP) From TMS

    For Wrist flexion and precision grip + rTMS/Sham rTMS and Wrist extension and precision grip + rTMS/Sham rTMS we measured the changes in the MEPs before the intervention(rTMS/Sham rTMS) at minute 0, 10, 30, and 60 and then again after at minute 0, 10, 30, and 60. The information below is separated first by wrist flexion or extension, then by study visit (rTMS or Sham rTMS), and finally by subject characteristic (SCI or control). This study is a crossover design, what that means is subjects (SCI and Controls) will participate in both sessions (rTMS and Sham rTMS). For rTMS/Sham rTMS/Sham rTMS over control brain area we measured the changes in the MEPs at minute 0, 10, 30, and 60.The information for this arm is separated by study visit: Session 1 is rTMS, Session 2 is Sham rTMS, and Session 3 is Sham rTMS over control brain area. For Training + rTMS and Training + Sham rTMS we measured the changes in the MEPs at baseline, post 5 training sessions, and post all training sessions.

    Time frame: Post rTMS, Sham rTMS, and Sham rTMS over control brain for all sessions at minute 0, 10, 30, and 60

  2. Electromyography (EMG)

    For rTMS/Sham rTMS/Sham rTMS over control brain area we measured voluntary output in hand muscles using EMG before and after the stimulation.The information for this arm is separated by study visit: Session 1 is rTMS, Session 2 is Sham rTMS, and Session 3 is Sham rTMS over control brain area.

    Time frame: Before and After the stimulation during each 2-hour session (rTMS/Sham rTMS/Sham rTMS over control brain area)

Secondary outcomes

  1. The Jebsen Taylor Hand Function Test (JTT)

    The JTT is a standardized test of several major aspects of hand function using simulated activities of daily living (writing, picking up small objects, picking up heavy objects etc.). The time taken to perform simulated activities of daily living is assessed. Lesser time to perform the activities would be considered a better outcome.

    Time frame: The JTT was measured at Baseline, Post 5 training sessions, and Post all training sessions at each 2-hour session.

07

Results

Posted Nov 4, 2020

Participant flow

Participant flow — Overall Study
MilestoneWrist Flexion and Precision Grip + rTMS and Sham rTMSWrist Extension and Precision Grip + rTMS and Sham rTMSrTMS/Sham rTMS/Sham rTMS Over Control Brain AreaTraining + rTMSTraining + Sham rTMS
Started1010589
Sci55589
Control55000
Completed1010543
Not completed00046
Withdrew: Some subjects were unable to commit to the training study.00046

Outcome measures

PrimaryPhysiology Measurements Before and After rTMS/Sham rTMS Protocol- Changes in Amplitude of Motor Evoked Potential (MEP) From TMS

For Wrist flexion and precision grip + rTMS/Sham rTMS and Wrist extension and precision grip + rTMS/Sham rTMS we measured the changes in the MEPs before the intervention(rTMS/Sham rTMS) at minute 0, 10, 30, and 60 and then again after at minute 0, 10, 30, and 60. The information below is separated first by wrist flexion or extension, then by study visit (rTMS or Sham rTMS), and finally by subject characteristic (SCI or control). This study is a crossover design, what that means is subjects (SCI and Controls) will participate in both sessions (rTMS and Sham rTMS). For rTMS/Sham rTMS/Sham rTMS over control brain area we measured the changes in the MEPs at minute 0, 10, 30, and 60.The information for this arm is separated by study visit: Session 1 is rTMS, Session 2 is Sham rTMS, and Session 3 is Sham rTMS over control brain area. For Training + rTMS and Training + Sham rTMS we measured the changes in the MEPs at baseline, post 5 training sessions, and post all training sessions.

Time frame:
Post rTMS, Sham rTMS, and Sham rTMS over control brain for all sessions at minute 0, 10, 30, and 60
Reported as:
Mean · millivolts (mV)
Physiology Measurements Before and After rTMS/Sham rTMS Protocol- Changes in Amplitude of Motor Evoked Potential (MEP) From TMS
millivolts (mV)Wrist Flexion and Precision Grip + rTMS (SCI)Wrist Flexion and Precision Grip + Sham rTMS (SCI)Wrist Flexion and Precision Grip + rTMS (Control)Wrist Flexion and Precision Grip + Sham rTMS (Control)Wrist Extension and Precision Grip + rTMS (SCI)Wrist Extension and Precision Grip + Sham rTMS (SCI)Wrist Extension and Precision Grip + rTMS (Control)Wrist Extension and Precision Grip + Sham rTMS (Control)rTMS/Sham rTMS/Sham rTMS Over Control Brain AreaTraining + rTMSTraining + Sham rTMS
Before: minute 00.31 ± 0.520.43 ± 0.770.45 ± 0.810.65 ± 1.120.33 ± 0.920.44 ± 0.610.59 ± 0.980.52 ± 0.83———
Before: minute 100.33 ± 0.560.39 ± 0.880.47 ± 1.120.71 ± 1.080.37 ± 0.830.46 ± 0.720.66 ± 1.020.56 ± 1.06———
Before: minute 300.36 ± 0.830.41 ± 0.800.51 ± 0.520.68 ± 0.910.42 ± 1.170.45 ± 0.930.63 ± 1.070.53 ± 0.92———
Before: minute 600.39 ± 1.020.42 ± 0.650.53 ± 0.850.72 ± 1.150.45 ± 0.980.42 ± 1.020.65 ± 0.970.61 ± 0.82———
After: minute 00.36 ± 1.030.45 ± 0.810.49 ± 1.260.66 ± 0.820.44 ± 0.670.61 ± 0.980.66 ± 1.030.57 ± 0.91———
After: minute 100.35 ± 0.830.44 ± 0.790.51 ± 0.350.71 ± 1.130.41 ± 1.020.59 ± 1.030.71 ± 0.980.63 ± 0.70———
After: minute 300.50 ± 1.440.43 ± 0.610.50 ± 0.810.73 ± 0.910.42 ± 0.910.63 ± 1.120.72 ± 1.040.61 ± 1.02———
After: minute 600.55 ± 1.180.44 ± 0.710.55 ± 0.330.74 ± 0.780.46 ± 0.880.66 ± 0.980.74 ± 1.120.62 ± 0.87———
Session 1: minute 0————————0.41 ± 0.52——
Session 1: minute 10————————0.47 ± 0.91——
Session 1: minute 30————————0.49 ± 0.82——
Session 1: minute 60————————0.52 ± 0.70——
Session 2: minute 0————————0.59 ± 0.98——
Session 2: minute 10————————0.54 ± 0.77——
Session 2: minute 30————————0.61 ± 1.03——
Session 2: minute 60————————0.58 ± 0.95——
Session 3: minute 0————————0.66 ± 1.02——
Session 3: minute 10————————0.67 ± 0.98——
Session 3: minute 30————————0.69 ± 1.28——
Session 3: minute 60————————0.70 ± 1.02——
Baseline—————————0.61 ± 0.790.61 ± 0.80
Post 5 training sessions—————————0.70 ± 0.920.68 ± 0.74
Post all training sessions—————————0.80 ± 0.830.69 ± 0.88
PrimaryElectromyography (EMG)

For rTMS/Sham rTMS/Sham rTMS over control brain area we measured voluntary output in hand muscles using EMG before and after the stimulation.The information for this arm is separated by study visit: Session 1 is rTMS, Session 2 is Sham rTMS, and Session 3 is Sham rTMS over control brain area.

Time frame:
Before and After the stimulation during each 2-hour session (rTMS/Sham rTMS/Sham rTMS over control brain area)
Reported as:
Mean · Millivolts (mV)
Electromyography (EMG)
Millivolts (mV)rTMS, Sham rTMS, Sham rTMS Over Control Brain Area
Session 1: Before0.138 ± 0.239
Session 1: After0.191 ± 0.323
Session 2: Before0.204 ± 0.361
Session 2: After0.208 ± 0.384
Session 3: Before0.221 ± 0.329
Session 3: After0.231 ± 0.352
SecondaryThe Jebsen Taylor Hand Function Test (JTT)

The JTT is a standardized test of several major aspects of hand function using simulated activities of daily living (writing, picking up small objects, picking up heavy objects etc.). The time taken to perform simulated activities of daily living is assessed. Lesser time to perform the activities would be considered a better outcome.

Time frame:
The JTT was measured at Baseline, Post 5 training sessions, and Post all training sessions at each 2-hour session.
Reported as:
Mean · Time (seconds)
The Jebsen Taylor Hand Function Test (JTT)
Time (seconds)Training + rTMSTraining + Sham rTMS
Baseline74.1 ± 21.688.6 ± 19.6
Post 5 training sessions54.4 ± 13.979.3 ± 18.7
Post all training sessions44.8 ± 15.284.8 ± 14.2

Adverse events

Collected over The adverse event data was collected from baseline to completion of study visits for each participant, an average of 6 days for Arm 1 and an average of 3 weeks for Arm 2 and 3.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Wrist Flexion and Precision Grip + rTMS and Sham rTMS0/10 (0%)0/10 (0%)0/10 (0%)
Wrist Extension and Precision Grip + rTMS and Sham rTMS0/10 (0%)0/10 (0%)0/10 (0%)
rTMS/Sham rTMS/Sham rTMS Over Control Brain Area0/5 (0%)0/5 (0%)0/5 (0%)
Training + rTMS0/4 (0%)0/4 (0%)0/4 (0%)
Training + Sham rTMS0/3 (0%)0/3 (0%)0/3 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Wrist Flexion and Precision Grip + rTMS and Sham rTMS (SCI)Wrist Flexion and Precision Grip + rTMS and Sham rTMS (Controls)Wrist Extension and Precision Grip + rTMS and Sham rTMS (SCI)Wrist Extension and Precision Grip + rTMS and Sham rTMS (Controls)rTMS/Sham rTMS/Sham rTMS Over Control Brain AreaTraining + rTMSTraining + Sham rTMSTotal
<=18 years00000000
Between 18 and 65 years555554332
>=65 years00000000
Age, Continuous
Age, Continuous(years)Wrist Flexion and Precision Grip + rTMS and Sham rTMS (SCI)Wrist Flexion and Precision Grip + rTMS and Sham rTMS (Controls)Wrist Extension and Precision Grip + rTMS and Sham rTMS (SCI)Wrist Extension and Precision Grip + rTMS and Sham rTMS (Controls)rTMS/Sham rTMS/Sham rTMS Over Control Brain AreaTraining + rTMSTraining + Sham rTMSTotal
Median44 (30 to 58)48 (26 to 56)53 (37 to 58)51 (41 to 56)43 (23 to 61)45 (33 to 56)41 (30 to 55)45 (23 to 61)
Sex: Female, Male
Sex: Female, Male(Participants)Wrist Flexion and Precision Grip + rTMS and Sham rTMS (SCI)Wrist Flexion and Precision Grip + rTMS and Sham rTMS (Controls)Wrist Extension and Precision Grip + rTMS and Sham rTMS (SCI)Wrist Extension and Precision Grip + rTMS and Sham rTMS (Controls)rTMS/Sham rTMS/Sham rTMS Over Control Brain AreaTraining + rTMSTraining + Sham rTMSTotal
Female02311108
Male532443324
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Wrist Flexion and Precision Grip + rTMS and Sham rTMS (SCI)Wrist Flexion and Precision Grip + rTMS and Sham rTMS (Controls)Wrist Extension and Precision Grip + rTMS and Sham rTMS (SCI)Wrist Extension and Precision Grip + rTMS and Sham rTMS (Controls)rTMS/Sham rTMS/Sham rTMS Over Control Brain AreaTraining + rTMSTraining + Sham rTMSTotal
Hispanic or Latino344143221
Not Hispanic or Latino11121118
Unknown or Not Reported10020003
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Wrist Flexion and Precision Grip + rTMS and Sham rTMS (SCI)Wrist Flexion and Precision Grip + rTMS and Sham rTMS (Controls)Wrist Extension and Precision Grip + rTMS and Sham rTMS (SCI)Wrist Extension and Precision Grip + rTMS and Sham rTMS (Controls)rTMS/Sham rTMS/Sham rTMS Over Control Brain AreaTraining + rTMSTraining + Sham rTMSTotal
American Indian or Alaska Native00000000
Asian00100001
Native Hawaiian or Other Pacific Islander00110002
Black or African American131232214
White10011104
More than one race21111118
Unknown or Not Reported11100003
Region of Enrollment
Region of Enrollment(Participants)Wrist Flexion and Precision Grip + rTMS and Sham rTMS (SCI)Wrist Flexion and Precision Grip + rTMS and Sham rTMS (Controls)Wrist Extension and Precision Grip + rTMS and Sham rTMS (SCI)Wrist Extension and Precision Grip + rTMS and Sham rTMS (Controls)rTMS/Sham rTMS/Sham rTMS Over Control Brain AreaTraining + rTMSTraining + Sham rTMSTotal
United States555554332
08

Study locations

3 sites
  • Miami VA Healthcare System, Miami, FL
    Miami, Florida 33125, United States
  • Edward Hines Jr. VA Hospital, Hines, IL
    Hines, Illinois 60141-5000, United States
  • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
    Pittsburgh, Pennsylvania 15240, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Mar 1, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 11, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01915095
Lead sponsor
VA Office of Research and Development
Responsible party
Sponsor
First posted
Aug 2, 2013
Start date
Sep 1, 2017
Primary completion
Sep 1, 2019
Completion
Sep 1, 2019
Results posted
Nov 4, 2020
Last update
Jun 11, 2021

Study contacts

Monica A Perez, PhD
principal investigator · Edward Hines Jr. VA Hospital, Hines, IL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion